p53 is frequently mutated in Burkitt's lymphoma cell lines

Farrell, P.J.; Allan, G.J.; Shanahan, F.; Vousden, K.H.; Crook, T.

doi:10.1002/j.1460-2075.1991.tb07837.x

Cited by 254Cancer-related Molecular PathwaysLymphoma Diagnosis and TreatmentViral-associated cancers and disorders

p53 is frequently mutated in Burkitt's lymphoma cell lines

Open access

Farrell, P.J., Allan, G.J., Shanahan, F., Vousden, K.H., Crook, T.·1991·The EMBO Journal

DOI 10.1002/j.1460-2075.1991.tb07837.xPMC PMC452998

Open this paper in CoChat — free account Open PDF

Abstract

A panel of 12 Burkitt's lymphoma cell lines and four other B cell lines were tested for the presence of mutations in p53. Protein analysis using a mutant-specific antibody and sequencing of both cDNA and genomic DNA revealed changes relative to the standard p53 protein sequence in 12 of the 16 lines studied, including 10 of the BL lines. Mutation of p53 in the BL lines was usually accompanied by loss of the other allele of p53. Testing of the mutated p53 cDNAs for gain of transforming activity or loss of growth suppression activity showed that several of the BL mutants were functionally altered from wild-type p53.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1991.tb07837.x

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The RAJI cell line harbors the loss-of-function mutant alleles R213Q and Y234H.
“The cell line RAJI, which harbors the loss-of-function mutant alleles R213Q and Y234H [34–36] for p53 targets including TLR3 and p21 (Supplementary Figure S4A), was treated with the reactivating drugs RITA [36] and PRIMA-1 [37] as well as with the anticancer drugs doxorubicin (DXR) and 5-fluorouracil (5FU) to induce p53.”
From Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells (2016) · cites this paper as [35]
Table I (p. 2880) identifies Raji’s p53 mutation as R213Q, but does not list Y234H. The functional-analysis passage reports that Raji mutant p53 lost suppressor activity in one assay but retained it in another, so the unqualified description of both alleles as loss-of-function is not supported. (LLM, conf=0.90)
Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572 · see citing works
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,512 · see citing works
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 7,937 · see citing works
Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic acid-Cellulose
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,636 · see citing works
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765 · see citing works
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K. R., Signer, S. H., Davidson, N. E., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,730 · see citing works
Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.
McMaster, G. K., & Carmichael, G. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4835 · Cited by 2,406 · see citing works
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987 · see citing works
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,778 · see citing works
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.
Dalla‐Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,764 · see citing works
Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx
Hausen, H. Z., Schulte‐Holthausen, H., KLEIN, G., Henle, W., Henle, G., Clifford, P., & Santesson, L. (1970) · Nature · doi:10.1038/2281056a0 · Cited by 1,256 · see citing works
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S. K., Zou, Z., Pirollo, K. F., Blattner, W. A., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,210 · see citing works
Monoclonal antibodies specific for simian virus 40 tumor antigens
Harlow, E., Crawford, L. V., Pim, D. C., & Williamson, N. M. (1981) · Journal of Virology · doi:10.1128/jvi.39.3.861-869.1981 · Cited by 1,038 · see citing works
p53 mutations in colorectal cancer.
Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J., & Lane, D. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7555 · Cited by 1,002 · see citing works
Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
Gannon, J., Greaves, R. F., Iggo, R. D., & Lane, D. P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08279.x · Cited by 970 · see citing works
p53: oncogene or anti-oncogene?Preprint
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 796 · see citing works
Isolation of a transforming sequence from a human bladder carcinoma cell line
Shih, C., & Weinberg, R. A. (1982) · Cell · doi:10.1016/0092-8674(82)90100-3 · Cited by 783 · see citing works
p53 Functions as a Cell Cycle Control Protein in Osteosarcomas
Diller, L., Kassel, J., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M. C., Bressac, B., Öztürk, M., Baker, S. J., Vogelstein, B., et al. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.11.5772 · Cited by 775 · see citing works
Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769 · see citing works
Identification of a Gene Located at Chromosome 5q21 that Is Mutated in Colorectal Cancers
Kinzler, K. W., Nilbert, M. C., Vogelstein, B., Bryan, T. M., Levy, D. B., Smith, K. J., Preisinger, A. C., Hamilton, S. R., Hedge, P., MARKHAM, A. F., et al. (1991) · Science · doi:10.1126/science.1848370 · Cited by 754 · see citing works
Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 681 · see citing works
Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study
de Thé, G., Geser, A., Day, N., Tukei, P. M., Williams, E. H., Beri, D., Smith, P. G., Dean, A. G., Bornkamm, G. W., Feorino, P. M., et al. (1978) · Nature · doi:10.1038/274756a0 · Cited by 613 · see citing works
Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
Bártek, J., Iggo, R. D., Gannon, J., & Lane, D. P. (1990) · PubMed · Cited by 603 · see citing works
A study of malignant tumours in Nigeria by short-term tissue culture
Pulvertaft, R. J. V. (1965) · Journal of Clinical Pathology · doi:10.1136/jcp.18.3.261 · Cited by 583 · see citing works
Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes
Hammerschmidt, W., & Sugden, B. (1989) · Nature · doi:10.1038/340393a0 · Cited by 552 · see citing works
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
Chiba, I., Takahashi, T., Nau, M. M., D'Amico, D., Dt, C., Mitsudomi, T., Buchhagen, D. L., Carbone, D. P., Piantadosi, S., & KOGA, H. (1990) · PubMed · Cited by 514 · see citing works
Isolation of human‐p53‐specific monoclonal antibodies and their use in the studies of human p53 expression
Banks, L., Matlashewski, G., & Crawford, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09919.x · Cited by 505 · see citing works
Primary Structure Polymorphism at Amino Acid Residue 72 of Human p53
Matlashewski, G., Tuck, S., Pim, D. C., Lamb, P., Schneider, J., & Crawford, L. V. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.961 · Cited by 497 · see citing works
Epstein-Barr Virus: Transformation, Cytopathic Changes, and Viral Antigens in Squirrel Monkey and Marmoset Leukocytes
Miller, G., Shope, T. C., Lisco, H., Stitt, D., & Lipman, M. B. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.2.383 · Cited by 440 · see citing works
An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by in vitro Infection
Klein, G., Giovanella, B. C., Westman, A., Stehlin, J. S., & Mumford, D. (1975) · Intervirology · doi:10.1159/000149930 · Cited by 426 · see citing works
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
Hinds, P. W., Finlay, C. A., Quartin, R. S., Baker, S. J., Fearon, E. R., Vogelstein, B., & Levine, A. J. (1990) · PubMed · Cited by 408 · see citing works
Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menézes, J., Leibold, W., Klein, G., & Clements, G. R. (1975) · PubMed · Cited by 387 · see citing works
Frequent mutation of the p53 gene in human esophageal cancer.
Hollstein, M. C., Metcalf, R. A., Welsh, J. A., Montesano, R., & Harris, C. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9958 · Cited by 383 · see citing works
Characterization of the Human p53 Gene
Lamb, P., & Crawford, L. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1379 · Cited by 328 · see citing works
Comparison of the in vitro transforming activities of human papillomavirus types.
Storey, A., Pim, D. C., Murray, A., Osborn, K., Banks, L., & Crawford, L. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03013.x · Cited by 301 · see citing works
Etiology of Burkitt's Lymphoma—an Alternative Hypothesis to a Vectored Virus
Burkitt, D. P. (1969) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/42.1.19 · Cited by 263 · see citing works
Cross‐linking of cell surface immunoglobulins induces epstein‐barr virus in burkitt lymphoma lines
Takada, K. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910330106 · Cited by 249 · see citing works
Different Tumor-Derived p53 Mutants Exhibit Distinct Biological Activities
Halevy, O., Michalovitz, D., & Oren, M. (1990) · Science · doi:10.1126/science.2218501 · Cited by 234 · see citing works
Cloning of Immunoglobulin-Producing Human Leukemic and Lymphoma Cells in Long-Term Cultures.
Hinuma, Y., & Grace, J. T. (1967) · Experimental Biology and Medicine · doi:10.3181/00379727-124-31677 · Cited by 216 · see citing works
Restricted expression of EBV latent genes and T‐lymphocyte‐detected membrane antigen in Burkitt's lymphoma cells.
Rowe, D., Rowe, M., Evan, G. I., Wallace, L. E., Farrell, P. J., & Rickinson, A. B. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04540.x · Cited by 196 · see citing works
Self-citation
Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
Stratton, M. R., Moss, S., Warren, W., Patterson, H., Clark, J. A., Fisher, C., Fletcher, C., Ball, A., Thomas, M., & Gusterson, B. A. (1990) · PubMed · Cited by 177 · see citing works
Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.
Benchimol, S., Pim, D. C., & Crawford, L. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01296.x · Cited by 170 · see citing works
Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours.
Prosser, J., Thompson, A. M., Cranston, G., & Evans, H. J. (1990) · PubMed · Cited by 167 · see citing works
Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line
King, W. E., Thomas-Powell, A. L., Raab‐Traub, N., Hawke, M., & Kieff, E. D. (1980) · Journal of Virology · doi:10.1128/jvi.36.2.506-518.1980 · Cited by 164 · see citing works
Relationship between the sensitivity of EBV‐carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome
Klein, G., & Dombos, L. (1973) · International Journal of Cancer · doi:10.1002/ijc.2910110210 · Cited by 148 · see citing works
Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.
van Santen, V. L., Cheung, A. K., & Kieff, E. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.3.1930 · Cited by 134 · see citing works
Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells
Biggin, M. D., Bodescot, M., Perricaudet, M., & Farrell, P. J. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3120-3132.1987 · Cited by 133 · see citing works
Self-citation
Immunologically Distinct p53 Molecules Generated by Alternative Splicing
Arai, N., Nomura, D., Yokota, K., Wolf, D., Brill, E., Shohat, O., & Rotter, V. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3232 · Cited by 126 · see citing works
The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma.
Lenoir, G. M., Vuillaume, M., & Bonnardel, C. (1985) · PubMed · Cited by 125 · see citing works
Long-Term Cultivation of Hypodiploid Human Tumor Cells 2 3
Auersperg, N. (1964) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/32.1.135 · Cited by 110 · see citing works
Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]
Nakamura, Y., Ballard, L., Leppert, M., O'Connell, P., Lathrop, M. G., Lalouel, J.-M., & White, R. L. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.12.5707 · Cited by 92 · see citing works
Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.
Wilkinson, D. M., de Vries, R. R., Madrigal, J. A., Lock, C., Morgenstern, J. P., Trowsdale, J., & Altmann, D. M. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.4.1442 · Cited by 65 · see citing works
Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda
Geser, A., Lenoir, G., Anvret, M., Bornkamm, G. W., Klein, G., Williams, E. H., Wright, D. H., & de Thé, G. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(93)90009-t · Cited by 57 · see citing works
A hypervariable RFLP on chromosome 17pl3 is defined by an arbitrary single copy probe pl44-D6 [HGM9 No. D17S34]
Kondoleon, S. K., Vissing, H., Luo, X. Y., Magenis, R. E., Kellogg, J. A., & Litt, M. J. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.24.10605 · Cited by 56 · see citing works
Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression
Crook, T., Fisher, C., & Vousden, K. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.505-510.1991 · Cited by 32 · see citing works
Self-citation

Flagged first, then by citations

4 of the 59 references couldn’t be matched to a known paper.

Research works printed but not linked: 13

Aviv,H. and Leder,P. (1972) Proc. Nat!. Acad. Sci. USA, 64, 1408-1412.
Dalla-Favera,R., Brejni,M., Erikson,J., Patterson,D., Gallo, R.C. and Croce,C.M. (1982) Proc. Natl. Acad. Sci. USA, 79, 7824-7827.
Eliyahu,D., Michalovitz,D., Eliyahu,S., Pinhasi-Kimhi,O. and Oren,M. (1989) Proc. Natl. Acad. Sci. USA, 86, 8763-8767.
Hinuma,Y. and Grace,J.T. (1967) Proc. Soc. Exp. Biol. Med., 124, 107-111.
Hollstein,M.C., Metcalf,R.A., Welsh,J.A., Montesano,R. and Harris,C.C. (1990) Proc. Natl. Acad. Sci. USA, 87, 9958-9961.
Lenoir,G.M., Vuillaume,M. and Bonnardel,C. (1985) IARC Publications No 60, pp. 309-318.
McMaster,G.K. and Carmichael,G.C. (1977) Proc. Natl. Acad. Sci. USA, 74, 4835-4838.
Miller,G., Shope,T., Lisco,H., Stitt,D. and Lipman,M. (1972) Proc. Natl. Acad. Sci. USA, 69, 383-387
Rodrigues,N.R., Rowan,A., Smith,M.E.G., Kerr,I.B., Bodmer,W.F., Gannon,J.F. and Lane,D.P. (1990) Proc. Natl. Acad. Sci. USA, 87, 7555 -7559.
Sanger,F., Nicklen,S. and Coulson,A.R. (1977) Proc. Natl. Acad. Sci. USA, 74, 5463-5467.
Thomas,P.S. (1980) Proc. Natl. Acad. Sci. USA, 77, 5201-5205.
van Santen,V., Cheung,A. and Kieff,E. (1981) Proc. Natl. Acad. Sci. USA, 78, 1930-1934
zur Hausen,H., Schulte-Holthausen,H., Klein,G., Henle,W., Henle,G., Clifford,P. and Santesson,L. (1970) Nature, 228, 1056-1058. Received on April 30, 1991; revised on June 5, 1991 Note added in proof Mutations of p53 in BL have also been reported recently by Gaidano et al. (1991) (Proc. Natl. Acad. Sci. USA, 88. 5413-5417).

Sorted by citations

Proteins of the Myc network: essential regulators of cell growth and differentiation.
Henriksson, M., & Lüscher, B. (1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 823 · see citing works
High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma
Metzler, M., Wilda, M., Busch, K., Viehmann, S. F., & Borkhardt, A. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10316 · Cited by 543 · see citing works
Epstein–Barr Virus and Cancer
Farrell, P. J. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 542 · see citing works
Self-citation
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Preprint
Wagner, A. J., Kokontis, J. M., & Hay, N. (1994) · Genes & Development · doi:10.1101/gad.8.23.2817 · Cited by 540 · see citing works
Germline Mutations of the p53 Tumor-Suppressor Gene in Children and Young Adults with Second Malignant Neoplasms
Malkin, D. M., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Børresen‐Dale, A., Li, F. P., Garber, J. E., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262002 · Cited by 378 · see citing works
Multifactorial analysis of p53 alteration in human cancer: A review
Soussi, T., Legros, Y., Lubin, R., Ory, K., & Schlichtholz, B. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570102 · Cited by 351 · see citing works
The role of immunoglobulin translocations in the pathogenesis of B-cell malignancies
Willis, T. G., & Dyer, M. J. S. (2000) · Blood · doi:10.1182/blood.v96.3.808.015k30_808_822 · Cited by 324 · see citing works
DNA methylation and cancer
Jones, P. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205597 · Cited by 321 · see citing works
EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
Székely, L., Selivanova, G., Magnússon, K. P., Klein, G. O., & Wiman, K. G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5455 · Cited by 309 · see citing works
Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours
Crook, T., Wrede, C. D., TIDY, J. A., Vousden, K. H., Wrede, C. D., TIDY, J. A., MASON, W. P., & Evans, D. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90662-m · Cited by 309 · see citing works
Self-citation
Epstein–Barr virus and Burkitt lymphoma
Brady, G., MacArthur, G. J., & Farrell, P. J. (2007) · Postgraduate Medical Journal · doi:10.1136/jcp.2007.047977 · Cited by 307 · see citing works
Self-citation
p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis
Greiner, T., Moynihan, M., Chan, W., Lytle, D. M., Pedersen, A., Anderson, J., & Weisenburger, D. D. (1996) · Blood · doi:10.1182/blood.v87.10.4302.bloodjournal87104302 · Cited by 285 · see citing works
Biology and disease associations of Epstein–Barr virus
Crawford, D. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0783 · Cited by 284 · see citing works
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
Kennedy, G. D., Komano, J. A., & Sugden, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336099100 · Cited by 275 · see citing works
p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.
Bakalkin, G. Y., Yakovleva, T., Selivanova, G., Magnússon, K. P., Székely, L., Владимировна, К. Е., Klein, G., Terenius, L. Y., & Wiman, K. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.413 · Cited by 274 · see citing works
Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53‐mediated repression of transcription.
Lechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H., & Laimins, L. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05375.x · Cited by 272 · see citing works
Self-citation
Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene
Fries, K., Miller, W. E., & Raab‐Traub, N. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8653-8659.1996 · Cited by 253 · see citing works
Latent and lytic Epstein‐Barr virus replication strategies
Tsurumi, T., Fujita, M., & Kudoh, A. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.441 · Cited by 242 · see citing works
Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929 · Cited by 237 · see citing works
Myc-Mediated Apoptosis Is Blocked by Ectopic Expression of Bcl-2
Wagner, A. J., Small, M. B., & Hay, N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.4.2432 · Cited by 218 · see citing works
Frequent mutations in the p53 gene in human myeloid leukemia cell lines
Sugimoto, K., Toyoshima, H., Sakai, R., Miyagawa, K., Hagiwara, K., Ishikawa, F., Takaku, F., Yazaki, Y., & Hirai, H. (1992) · Blood · doi:10.1182/blood.v79.9.2378.2378 · Cited by 213 · see citing works
Mutant conformation of p53
Stephen, C. W., & Lane, D. P. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90386-x · Cited by 211 · see citing works
Hepatitis C Virus Infection Activates the Immunologic (Type II) Isoform of Nitric Oxide Synthase and Thereby Enhances DNA Damage and Mutations of Cellular Genes
Machida, K., Cheng, K. T.-H., Sung, V. M.-H., Lee, K. J., Levine, A. M., & Lai, M. M. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.16.8835-8843.2004 · Cited by 191 · see citing works
p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time
Piris, M. A., Pezzella, F., Martínez-Montero, J. C., Orradre, J. L., Villuendas, R., Sánchez‐Beato, M., Cuena, R., Cruz, M., Martinez, B., Garrido, M., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.61 · Cited by 183 · see citing works
c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif.
Reisman, D., Elkind, N. B., Roy, B., Beamon, J., & Rotter, V. (1993) · PubMed · Cited by 182 · see citing works
Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood
Wada, M., Bartram, C., Nakamura, H., Hachiya, M., Chen, D., Borenstein, J. E., Cw, M., Ludwig, L., Hansen-Hagge, T., & Ludwig, W. (1993) · Blood · doi:10.1182/blood.v82.10.3163.3163 · Cited by 179 · see citing works
Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein–Barr virus
Kusano, M., Toyota, M., Suzuki, H., Akino, K., Aoki, F., Fujita, M., Hosokawa, M., Shinomura, Y., Imai, K., & Tokino, T. (2006) · Cancer · doi:10.1002/cncr.21789 · Cited by 167 · see citing works
Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53Preprint
Kelly, G. L., Grabow, S., Glaser, S. P., Fitzsimmons, L., Aubrey, B. J., Okamoto, T., Valente, L. J., Robati, M., Tai, L., Fairlie, W. D., et al. (2014) · Genes & Development · doi:10.1101/gad.232009.113 · Cited by 166 · see citing works
Cyclin G1 and Cyclin G2 Comprise a New Family of Cyclins with Contrasting Tissue-specific and Cell Cycle-regulated Expression
Horne, M. C., Goolsby, G. L., Donaldson, K. L., Tran, D., Neubauer, M., & Wahl, A. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.11.6050 · Cited by 160 · see citing works
Epstein-barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation
Gulley, M. L., Pulitzer, D. R., Eagan, P. A., & Schneider, B. (1996) · Human Pathology · doi:10.1016/s0046-8177(96)90133-1 · Cited by 159 · see citing works
The role of Epstein–Barr virus in cancer
Pattle, S. B., & Farrell, P. J. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.11.1193 · Cited by 154 · see citing works
Self-citation
Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers
Bornkamm, G. W. (2008) · International Journal of Cancer · doi:10.1002/ijc.24223 · Cited by 150 · see citing works
Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.
Crook, T., & Vousden, K. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05487.x · Cited by 146 · see citing works
Self-citation
Epstein-Barr Virus-Induced Changes in B-Lymphocyte Gene Expression
Carter, K. L., Cahir-McFarland, E. D., & Kieff, E. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10427-10436.2002 · Cited by 144 · see citing works
An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.
Sun, Y., Hegamyer, G. A., Cheng, Y. J., Hildesheim, A., Chen, J. Y., Chen, I.-H., Cao, Y., Yao, K., & Colburn, N. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6516 · Cited by 143 · see citing works
Alterations of the p53 gene in nasopharyngeal carcinoma
Effert, P. J., McCoy, R., Abdel‐Hamid, M., Flynn, K., Zhang, Q., Busson, P., Tursz, T., Liu, E., & Raab‐Traub, N. (1992) · Journal of Virology · doi:10.1128/jvi.66.6.3768-3775.1992 · Cited by 137 · see citing works
C-myc overexpression and p53 loss cooperate to promote genomic instability
Yin, X.-Y., Grove, L. E., Datta, N. S., Long, M. W., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202410 · Cited by 136 · see citing works
Attenuating the p53 Pathway in Human Cancers: Many Means to the Same EndPreprint
Wasylishen, A. R., & Lozano, G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026211 · Cited by 128 · see citing works
Transcriptional silencing of Polo-like kinase 2(SNK/PLK2)is a frequent event in B-cell malignancies
Syed, N., Smith, P., Sullivan, A., Spender, L. C., Dyer, M. J. S., Karran, L., O’Nions, J., Allday, M. J., Hoffmann, I., Crawford, D., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1194 · Cited by 129 · see citing works
Self-citation
The Oscar-worthy role of Myc in apoptosis
Meyer, N., Kim, S. S., & Penn, L. Z. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.011 · Cited by 127 · see citing works
Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma
Ruf, I. K., Rhyne, P., Yang, H. J., Borza, C. M., Hutt‐Fletcher, L. M., Cleveland, J. L., & Sample, J. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1651 · Cited by 127 · see citing works
Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with posttransplant lymphoproliferative disorders
Cen, H., Williams, P., McWilliams, H., Breinig, M., Ho, M., & McKnight, J. (1993) · Blood · doi:10.1182/blood.v81.5.1393.1393 · Cited by 121 · see citing works
p53 Abnormalities in B-Cell Prolymphocytic Leukemia
Lens, D., Schouwer, P. J. J. C. D., Hamoudi, R., Abdul-Rauf, M., Farahat, N. M. G., Matutes, E., Crook, T., Dyer, M. J. S., & Catovsky, D. (1997) · Blood · doi:10.1182/blood.v89.6.2015 · Cited by 120 · see citing works
Self-citation
Oncolytic parvoviruses as cancer therapeutics
Rommelaere, J., Geletneky, K., Angelova, A. L., Daeffler, L., Dinsart, C., Kiprianova, I., Schlehofer, J. R., & Raykov, Z. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.02.011 · Cited by 118 · see citing works
UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53
Wu, H., Pomeroy, S. L., Ferreira, M., Teider, N., Mariani, J., Nakayama, K. I., Hatakeyama, S., Tron, V. A., Saltibus, L. F., Spyracopoulos, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2283 · Cited by 117 · see citing works
Transactivation of the Human p53 Tumor Suppressor Gene by c-Myc/Max Contributes to Elevated Mutant p53 Expression in Some Tumors
Roy, B., Beamon, J., Bálint, É., & Reisman, D. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7805 · Cited by 118 · see citing works
The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia, K. G., Gutiérrez, M. I., Huppi, K. E., Siwarski, D. F., & MAGRATH, I. T. (1992) · PubMed · Cited by 113 · see citing works
The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features
Braziel, R. M. (2001) · Blood · doi:10.1182/blood.v97.12.3713 · Cited by 113 · see citing works
Role of genetic and epigenetic changes in Burkitt lymphoma
Lindström, M. S., & Wiman, K. G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00058-5 · Cited by 111 · see citing works
The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene
Reisman, D., & Rotter, V. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.2.345 · Cited by 108 · see citing works
Epstein-Barr Virus Small RNAs Potentiate Tumorigenicity of Burkitt Lymphoma Cells Independently of an Effect on Apoptosis
Ruf, I. K., Rhyne, P., Yang, C., Cleveland, J. L., & Sample, J. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10223-10228.2000 · Cited by 112 · see citing works
DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective.
Allday, M. J., Inman, G. J., Crawford, D., & Farrell, P. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00182.x · Cited by 109 · see citing works
Self-citation
Evidence That Dynamin-2 Functions as a Signal-Transducing Gtpase
Fish, K. N., Schmid, S. L., & Damke, H. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.1.145 · Cited by 107 · see citing works
Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines
Delecluse, H., Bartnizke, S., Hammerschmidt, W., Bullerdiek, J., & Bornkamm, G. W. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1292-1299.1993 · Cited by 107 · see citing works
Epstein‐Barr virus efficiently immortalizes human B cells without neutralizing the function of p53.
Allday, M. J., Sinclair, A. J., Parker, G. A., Crawford, D., & Farrell, P. J. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07124.x · Cited by 107 · see citing works
Self-citation
The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.
Slingerland, J., Jenkins, J. R., & Benchimol, S. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05744.x · Cited by 105 · see citing works
The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations
Villuendas, R., Piris, M., Algara, P., Sánchez‐Beato, M., Sánchez‐Verde, L., Martinez, J., Orradre, J., García, P., López, C. G. A., & Martinez, P. (1993) · Blood · doi:10.1182/blood.v82.10.3151.3151 · Cited by 105 · see citing works
Functional and Physical Interaction between p53 and BZLF1: Implications for Epstein-Barr Virus Latency
Zhang, Q., Gutsch, D. E., & Kenney, S. C. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1929-1938.1994 · Cited by 104 · see citing works
Reactivation of Lytic Replication from B Cells Latently Infected with Epstein-Barr Virus Occurs with High S-Phase Cyclin-Dependent Kinase Activity while Inhibiting Cellular DNA Replication
Kudoh, A., Fujita, M., Kiyono, T., Kuzushima, K., Sugaya, Y., Izuta, S., Nishiyama, Y., & Tsurumi, T. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.851-861.2003 · Cited by 99 · see citing works
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53
Lindström, M. S., Klangby, U., & Wiman, K. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204303 · Cited by 98 · see citing works
The Epstein-Barr Virus (EBV)-Induced Tumor Suppressor MicroRNA MiR-34a Is Growth Promoting in EBV-Infected B Cells
Forte, E., Salinas, R. E., Chang, C., Zhou, T., Linnstaedt, S. D., Gottwein, E., Jacobs, C., Jima, D., Li, Q.-J., Dave, S. S., et al. (2012) · Journal of Virology · doi:10.1128/jvi.07056-11 · Cited by 97 · see citing works
p16/INK4a and p15/INK4b Gene Methylation and Absence of p16/INK4a mRNA and Protein Expression in Burkitt's Lymphoma
Klangby, U., Okan, İ., Magnússon, K. P., Wendland, M., Lind, P., & Wiman, K. G. (1998) · Blood · doi:10.1182/blood.v91.5.1680 · Cited by 93 · see citing works
Burkitt's Lymphoma: Molecular Pathogenesis and Treatment
Bishop, P. C., Rao, V., & Wilson, W. H. (2000) · Cancer Investigation · doi:10.3109/07357900009012197 · Cited by 92 · see citing works
p53 mutations are absent from carcinogen‐induced mouse liver tumors but occur in cell lines established from these tumors
Kress, S., König, J., Schweizer, J., Löhrke, H., Bauer-Hofmann, R., & Schwarz, M. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940060210 · Cited by 92 · see citing works
P53 overexpression and Epstein‐Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas
Niedobitek, G., Agathanggelou, A., Barber, P. C., SMALLMAN, L. A., Jones, E. L., & Young, L. S. (1993) · The Journal of Pathology · doi:10.1002/path.1711700409 · Cited by 91 · see citing works
Viral infection and cancer
Morris, J. D. H., Eddleston, A. L. W. F., & Crook, T. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91510-9 · Cited by 83 · see citing works
Self-citation
The Cellular Ataxia Telangiectasia-Mutated Kinase Promotes Epstein-Barr Virus Lytic Reactivation in Response to Multiple Different Types of Lytic Reactivation-Inducing Stimuli
Hagemeier, S. R., Barlow, E. A., Meng, Q., & Kenney, S. C. (2012) · Journal of Virology · doi:10.1128/jvi.01850-12 · Cited by 82 · see citing works
Epstein-Barr virus and Burkitt lymphoma
Rowe, M., Fitzsimmons, L., & Bell, A. I. (2014) · 癌症：英文版 · doi:10.5732/cjc.014.10190 · Cited by 80 · see citing works
EBV and Apoptosis: The Viral Master Regulator of Cell Fate?
Fitzsimmons, L., & Kelly, G. L. (2017) · Viruses · doi:10.3390/v9110339 · Cited by 79 · see citing works
Immunolocalization of Human p14ARF to the Granular Component of the Interphase Nucleolus
Lindström, M. S., Klangby, U., Inoue, R., Pisa, P., Wiman, K. G., & Asker, C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4854 · Cited by 76 · see citing works
Lowp53 protein expression in salivary gland tumours compared with lung carcinomas
Soini, Y., Kamel, D., Nuorva, K., Lane, D. P., Vähäkangas, K., & Pääkkö, P. K. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01606914 · Cited by 75 · see citing works
Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-kappaB activity
Chen, W., & Cooper, N. R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4849-4853.1996 · Cited by 72 · see citing works
p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?
Drexler, H. G., Fombonne, S., Matsuo, Y., Hu, Z.-B., Hamaguchi, H., & Uphoff, C. (2000) · Leukemia · doi:10.1038/sj.leu.2401604 · Cited by 71 · see citing works
Inhibition of S-Phase Cyclin-Dependent Kinase Activity Blocks Expression of Epstein-Barr Virus Immediate-Early and Early Genes, Preventing Viral Lytic Replication
Kudoh, A., Daikoku, T., Sugaya, Y., Isomura, H., Fujita, M., Kiyono, T., Nishiyama, Y., & Tsurumi, T. (2003) · Journal of Virology · doi:10.1128/jvi.78.1.104-115.2004 · Cited by 67 · see citing works
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins
Fitzsimmons, L., Cartlidge, R., Chang, C. W. T., Sejic, N., Galbraith, L. C. A., Suraweera, C. D., Croom-Carter, D. S. G., Dewson, G., Tierney, R. J., Bell, A. I., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0435-1 · Cited by 65 · see citing works
Epstein–Barr virus and its role in the pathogenesis of Burkitt's lymphoma: An unresolved issue
Bornkamm, G. W. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.07.002 · Cited by 64 · see citing works
Initial testing of the MDM2 inhibitor RG7112 by the pediatric preclinical testing program
Carol, H., Reynolds, C. P., Kang, M. H., Keir, S. T., Maris, J. M., Gorlick, R. G., Kolb, E. A., Billups, C. A., Geier, B., Kurmasheva, R. T., et al. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24235 · Cited by 64 · see citing works
p53 Immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours
Soini, Y., Vähäkangas, K., Nuorva, K., Kamel, D., Lane, D. P., & Pääkkö, P. K. (1992) · The Journal of Pathology · doi:10.1002/path.1711680106 · Cited by 62 · see citing works
The Oncogenic Potential of Epstein-Barr Virus Nuclear Antigen 1 in Transgenic Mice
Wilson, J. B., & Levine, A. J. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77633-5_48 · Cited by 62 · see citing works
Viruses and tumours – an update
Talbot, S. J., & Crawford, D. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.11.039 · Cited by 61 · see citing works
Comparative analysis ofp53 protein immunoreactivity in prostatic, lung and breast carcinomas
Soini, Y., Pääkkö, P. K., Nuorva, K., Kamel, D., Lane, D. P., & Vähäkangas, K. (1992) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01611179 · Cited by 61 · see citing works
Inactivation of the ARF–MDM-2–p53 pathway in sporadic Burkitt's lymphoma in children
Wilda, M., Bruch, J., Harder, L., Rawer, D., Reiter, A., Borkhardt, A., & Woessmann, W. (2003) · Leukemia · doi:10.1038/sj.leu.2403254 · Cited by 59 · see citing works
Mutation and protein expression of p53 in acquired immunodeficiency syndrome-related lymphomas
Nakamura, H., Said, J. W., Cw, M., & Koeffler, H. (1993) · Blood · doi:10.1182/blood.v82.3.920.920 · Cited by 60 · see citing works
UBE4B, a ubiquitin chain assembly factor, is required for MDM2-mediated p53 polyubiquitination and degradation
Wu, H., & Leng, R. P. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15882 · Cited by 57 · see citing works
Inactivation of Nuclear Factor-κB by citrus flavanone hesperidin contributes to apoptosis and chemo-sensitizing effect in Ramos cells
Nazari, M., Ghorbani, A., Hekmatdoost, A., Jeddi‐Tehrani, M., & Zand, H. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.10.053 · Cited by 58 · see citing works
Bcl-2 Does Not Protect Burkitt's Lymphoma Cells From Oxidant-Induced Cell Death
Lee, Y.-J., & Shacter, E. B. (1997) · Blood · doi:10.1182/blood.v89.12.4480 · Cited by 58 · see citing works
Expression of p16INK4A and p14ARF in hematological malignancies
Taniguchi, T., Chikatsu, N., Takahashi, S., Fujita, A., Uchimaru, K., Asano, S., Fujita, T., & Motokura, T. (1999) · Leukemia · doi:10.1038/sj.leu.2401557 · Cited by 55 · see citing works
Alterations of the p53 tumor suppressor gene in diffuse large cell lymphomas with translocations of the c-MYC and BCL-2 proto-oncogenes
Farrugia, M. M., Duan, L., Reis, M., Ngan, B., & Berinstein, N. L. (1994) · Blood · doi:10.1182/blood.v83.1.191.191 · Cited by 54 · see citing works
Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma.
Sun, Y., Nakamura, K., Wendel, E. J., & Colburn, N. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.7.2827 · Cited by 54 · see citing works
Resistance to TGF-β1 correlates with a reduction of TGF-β type II receptor expression in Burkitt’s lymphoma and Epstein–Barr virus-transformed B lymphoblastoid cell lines
Inman, G. J., & Allday, M. J. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-6-1567 · Cited by 53 · see citing works
Host cell requirements for efficient infection of quiescent primary B lymphocytes by Epstein-Barr virus
Sinclair, A. J., & Farrell, P. J. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5461-5468.1995 · Cited by 52 · see citing works
Self-citation
DNA Methylation and cancer
Spruck, C., Rideout, W. M., & Jones, P. A. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9118-9_22 · Cited by 52 · see citing works
Oncolytic Rat Parvovirus H-1PV, a Candidate for the Treatment of Human Lymphoma: In Vitro and In Vivo Studies
Angelova, A. L., Aprahamian, M., Balboni, G., Delecluse, H., Feederle, R., Kiprianova, I., Grekova, S. P., Galabov, A. S., Witzens‐Harig, M., Ho, A. D., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.78 · Cited by 51 · see citing works
Mycosis fungoides: Expression of C-myc p62 p53, bcl-2and PCNA Proteins and Absence of Association with Epstein-Barr Virus
Kanavaros, P., Ioannidou, D., Tzardi, M. N., Datseris, G., Katsantonis, J., Delidis, G., & Tosca, A. D. (1994) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)80423-1 · Cited by 51 · see citing works
The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults.
Banker, D. E., Radich, J. P., Becker, A., Kerkof, K., Norwood, T. H., Willman, C. L., & Appelbaum, F. R. (1998) · PubMed · Cited by 50 · see citing works
Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: Frequent loss of 19p13.3 and gain of 19q13.1-13.2
Höglund, M., Gorunova, L., Andrén‐Sandberg, Å., Dawiskiba, S., Mitelman, F., & Johansson, B. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199801)21:1 · Cited by 57 · see citing works
Docosahexaenoic acid sensitizes Ramos cells to Gamma-irradiation-induced apoptosis through involvement of PPAR-γ activation and NF-κB suppression
Zand, H., Rahimipour, A., Salimi, S., & Shafiee, S. M. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9838-x · Cited by 49 · see citing works
Viruses and Lymphomas
Pagano, J. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmp020056 · Cited by 49 · see citing works
p53 Mutations, c-myc and bcl-2 Rearrangements in Human Non-Hodgkin's Lymphoma Cell Lines
Chang, H., Blondal, J. A., Benchimol, S., Minden, M. D., & Messner, H. A. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509059672 · Cited by 45 · see citing works
Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas
Edwards, R. H., & Raab‐Traub, N. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1309-1315.1994 · Cited by 44 · see citing works

The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia, K. G., Gutiérrez, M. I., Huppi, K. E., Siwarski, D. F., & MAGRATH, I. T. (1992) · PubMed · Cited by 113 · see citing works
Advances in Brief The Pattern of p53 Mutations in Burkin's Lymphoma Differs from That of Solid Tumors
Bhatia, K. G., Gutierrez, M. I., Al, E., Res, C., Publications, C. T. A., Bhatia, K. G., Gutiã©rrez, M. I., Siwarski, D., & MAGRATH, I. T. (2013)
Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240.
Wiman, K. G., Magnússon, K. P., Ramqvist, T., & Klein, G. (1991) · PubMed · Cited by 70 · see citing works
A novel mutation in the p53 gene in a Burkitt's lymphoma cell line
Bhatia, K. G., Gutiérrez, M. I., & MAGRATH, I. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.3.207 · Cited by 6 · see citing works
An unusual p53 mutation detected in Burkitt's lymphoma: 30 bp duplication
Smardova (1994) · Oncology Reports · doi:10.3892/or_00000073 · Cited by 5 · see citing works

Authors: Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H., & Crook, T.
Affiliations: St Mary's Hospital (GB)
ORCID: Farrell, P.J.
Shanahan, F.
Vousden, K.H.
Crook, T.
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 1991-10-01
Volume: 10
Issue: 10
Pages: 2879-2887
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1002/j.1460-2075.1991.tb07837.x
PMC: PMC452998
OpenAlex: W196344020
Cited by: 254
References: 59
Citations by year: 2025: 3 · 2024: 1 · 2023: 2 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 12 · 2013: 1 · 2012: 14
FWCI: 9.46
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords: p53, Burkitt lymphoma, TP53 mutation, B-cell lymphoma cell lines, loss of heterozygosity, tumor suppressor
MeSH terms: Alleles, Amino Acid Sequence, Animals, Base Sequence, Burkitt Lymphoma, DNA, DNA, Neoplasm, Humans, Molecular Sequence Data, Mutation, Precipitin Tests, RNA, Neoplasm, Tumor Cells, Cultured, Blotting, Southern, Blotting, Northern, Blotting, Western, Polymerase Chain Reaction, Tumor Suppressor Protein p53

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 is frequently mutated in Burkitt's lymphoma cell lines

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks